nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—atherosclerosis	0.497	1	CbGaD
Toremifene—ABCB1—Ezetimibe—atherosclerosis	0.0469	0.152	CbGbCtD
Toremifene—ABCB1—Simvastatin—atherosclerosis	0.0436	0.141	CbGbCtD
Toremifene—ABCB1—Pravastatin—atherosclerosis	0.0427	0.138	CbGbCtD
Toremifene—ABCB1—Lovastatin—atherosclerosis	0.0427	0.138	CbGbCtD
Toremifene—CYP3A4—Rosuvastatin—atherosclerosis	0.0281	0.0909	CbGbCtD
Toremifene—CYP3A4—Ezetimibe—atherosclerosis	0.0281	0.0909	CbGbCtD
Toremifene—CYP3A4—Simvastatin—atherosclerosis	0.0261	0.0845	CbGbCtD
Toremifene—CYP3A4—Lovastatin—atherosclerosis	0.0256	0.0827	CbGbCtD
Toremifene—CYP3A4—Pravastatin—atherosclerosis	0.0256	0.0827	CbGbCtD
Toremifene—Foetor hepaticus—Ezetimibe—atherosclerosis	0.0026	0.0209	CcSEcCtD
Toremifene—Foetor hepaticus—Simvastatin—atherosclerosis	0.00248	0.0199	CcSEcCtD
Toremifene—Foetor hepaticus—Pravastatin—atherosclerosis	0.00224	0.018	CcSEcCtD
Toremifene—Liver disorder—Ezetimibe—atherosclerosis	0.00216	0.0174	CcSEcCtD
Toremifene—Liver disorder—Simvastatin—atherosclerosis	0.00206	0.0166	CcSEcCtD
Toremifene—Liver disorder—Pravastatin—atherosclerosis	0.00186	0.015	CcSEcCtD
Toremifene—Glaucoma—Niacin—atherosclerosis	0.00171	0.0138	CcSEcCtD
Toremifene—Cataract—Lovastatin—atherosclerosis	0.00158	0.0127	CcSEcCtD
Toremifene—Cataract—Simvastatin—atherosclerosis	0.00148	0.0119	CcSEcCtD
Toremifene—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00147	0.0119	CcSEcCtD
Toremifene—Skin discolouration—Niacin—atherosclerosis	0.00143	0.0115	CcSEcCtD
Toremifene—Hepatocellular injury—Simvastatin—atherosclerosis	0.00141	0.0113	CcSEcCtD
Toremifene—Cataract—Pravastatin—atherosclerosis	0.00133	0.0107	CcSEcCtD
Toremifene—Hepatocellular injury—Pravastatin—atherosclerosis	0.00127	0.0102	CcSEcCtD
Toremifene—Breast disorder—Rosuvastatin—atherosclerosis	0.00116	0.00936	CcSEcCtD
Toremifene—Hot flush—Ezetimibe—atherosclerosis	0.00114	0.00921	CcSEcCtD
Toremifene—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00113	0.00913	CcSEcCtD
Toremifene—Abnormal vision—Niacin—atherosclerosis	0.00113	0.00906	CcSEcCtD
Toremifene—Arthritis—Lovastatin—atherosclerosis	0.00112	0.00903	CcSEcCtD
Toremifene—Arthritis—Ezetimibe—atherosclerosis	0.0011	0.00886	CcSEcCtD
Toremifene—Arthritis—Simvastatin—atherosclerosis	0.00105	0.00845	CcSEcCtD
Toremifene—Clofedanol—HRH1—atherosclerosis	0.00104	0.215	CrCbGaD
Toremifene—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000987	0.00795	CcSEcCtD
Toremifene—Hot flush—Pravastatin—atherosclerosis	0.000986	0.00794	CcSEcCtD
Toremifene—Menopausal symptoms—Pravastatin—atherosclerosis	0.000977	0.00787	CcSEcCtD
Toremifene—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000972	0.00783	CcSEcCtD
Toremifene—Jaundice—Rosuvastatin—atherosclerosis	0.000967	0.00778	CcSEcCtD
Toremifene—Breast disorder—Ezetimibe—atherosclerosis	0.000967	0.00778	CcSEcCtD
Toremifene—Arthritis—Niacin—atherosclerosis	0.000964	0.00776	CcSEcCtD
Toremifene—Arthritis—Pravastatin—atherosclerosis	0.000949	0.00764	CcSEcCtD
Toremifene—Doxylamine—HRH1—atherosclerosis	0.000949	0.196	CrCbGaD
Toremifene—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000938	0.00755	CcSEcCtD
Toremifene—Diplopia—Pravastatin—atherosclerosis	0.000922	0.00743	CcSEcCtD
Toremifene—Affect lability—Pravastatin—atherosclerosis	0.000908	0.00731	CcSEcCtD
Toremifene—Mood swings—Pravastatin—atherosclerosis	0.000874	0.00703	CcSEcCtD
Toremifene—Liver function test abnormal—Niacin—atherosclerosis	0.000865	0.00696	CcSEcCtD
Toremifene—Liver function test abnormal—Pravastatin—atherosclerosis	0.000851	0.00686	CcSEcCtD
Toremifene—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000824	0.00663	CcSEcCtD
Toremifene—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000808	0.00651	CcSEcCtD
Toremifene—Jaundice—Ezetimibe—atherosclerosis	0.000803	0.00647	CcSEcCtD
Toremifene—Arrhythmia—Rosuvastatin—atherosclerosis	0.000795	0.0064	CcSEcCtD
Toremifene—Angina pectoris—Niacin—atherosclerosis	0.000788	0.00635	CcSEcCtD
Toremifene—Mental disorder—Rosuvastatin—atherosclerosis	0.00078	0.00628	CcSEcCtD
Toremifene—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00078	0.00628	CcSEcCtD
Toremifene—Angina pectoris—Pravastatin—atherosclerosis	0.000776	0.00625	CcSEcCtD
Toremifene—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00077	0.0062	CcSEcCtD
Toremifene—Jaundice—Simvastatin—atherosclerosis	0.000766	0.00617	CcSEcCtD
Toremifene—Bromodiphenhydramine—HRH1—atherosclerosis	0.000742	0.153	CrCbGaD
Toremifene—Weight increased—Pravastatin—atherosclerosis	0.000725	0.00584	CcSEcCtD
Toremifene—Jaundice—Niacin—atherosclerosis	0.000704	0.00566	CcSEcCtD
Toremifene—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000701	0.00564	CcSEcCtD
Toremifene—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000697	0.00561	CcSEcCtD
Toremifene—Myocardial infarction—Pravastatin—atherosclerosis	0.000697	0.00561	CcSEcCtD
Toremifene—Jaundice—Pravastatin—atherosclerosis	0.000693	0.00558	CcSEcCtD
Toremifene—Sweating—Niacin—atherosclerosis	0.000692	0.00557	CcSEcCtD
Toremifene—Chills—Lovastatin—atherosclerosis	0.000677	0.00545	CcSEcCtD
Toremifene—Angiopathy—Ezetimibe—atherosclerosis	0.000671	0.00541	CcSEcCtD
Toremifene—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000667	0.00537	CcSEcCtD
Toremifene—Alopecia—Lovastatin—atherosclerosis	0.000667	0.00537	CcSEcCtD
Toremifene—Alopecia—Ezetimibe—atherosclerosis	0.000654	0.00526	CcSEcCtD
Toremifene—Mental disorder—Ezetimibe—atherosclerosis	0.000648	0.00522	CcSEcCtD
Toremifene—Malnutrition—Ezetimibe—atherosclerosis	0.000644	0.00519	CcSEcCtD
Toremifene—Back pain—Lovastatin—atherosclerosis	0.000635	0.00512	CcSEcCtD
Toremifene—Chills—Simvastatin—atherosclerosis	0.000633	0.0051	CcSEcCtD
Toremifene—Visual impairment—Niacin—atherosclerosis	0.000624	0.00503	CcSEcCtD
Toremifene—Alopecia—Simvastatin—atherosclerosis	0.000624	0.00502	CcSEcCtD
Toremifene—Back pain—Ezetimibe—atherosclerosis	0.000623	0.00502	CcSEcCtD
Toremifene—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00062	0.00499	CcSEcCtD
Toremifene—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000619	0.00499	CcSEcCtD
Toremifene—Vision blurred—Lovastatin—atherosclerosis	0.000619	0.00498	CcSEcCtD
Toremifene—Mental disorder—Simvastatin—atherosclerosis	0.000618	0.00498	CcSEcCtD
Toremifene—Tremor—Lovastatin—atherosclerosis	0.000615	0.00495	CcSEcCtD
Toremifene—Visual impairment—Pravastatin—atherosclerosis	0.000615	0.00495	CcSEcCtD
Toremifene—Eye disorder—Niacin—atherosclerosis	0.000605	0.00488	CcSEcCtD
Toremifene—Vertigo—Lovastatin—atherosclerosis	0.00059	0.00475	CcSEcCtD
Toremifene—Angiopathy—Niacin—atherosclerosis	0.000588	0.00473	CcSEcCtD
Toremifene—Leukopenia—Lovastatin—atherosclerosis	0.000588	0.00473	CcSEcCtD
Toremifene—Chills—Niacin—atherosclerosis	0.000581	0.00468	CcSEcCtD
Toremifene—Vision blurred—Simvastatin—atherosclerosis	0.000579	0.00466	CcSEcCtD
Toremifene—Arrhythmia—Niacin—atherosclerosis	0.000579	0.00466	CcSEcCtD
Toremifene—Tremor—Simvastatin—atherosclerosis	0.000575	0.00463	CcSEcCtD
Toremifene—Alopecia—Niacin—atherosclerosis	0.000573	0.00461	CcSEcCtD
Toremifene—Chills—Pravastatin—atherosclerosis	0.000572	0.00461	CcSEcCtD
Toremifene—Insomnia—Rosuvastatin—atherosclerosis	0.000572	0.00461	CcSEcCtD
Toremifene—Arrhythmia—Pravastatin—atherosclerosis	0.00057	0.00459	CcSEcCtD
Toremifene—Malnutrition—Niacin—atherosclerosis	0.000564	0.00454	CcSEcCtD
Toremifene—Alopecia—Pravastatin—atherosclerosis	0.000564	0.00454	CcSEcCtD
Toremifene—Chest pain—Lovastatin—atherosclerosis	0.000559	0.0045	CcSEcCtD
Toremifene—Ospemifene—ESR1—atherosclerosis	0.000552	0.114	CrCbGaD
Toremifene—Vertigo—Simvastatin—atherosclerosis	0.000552	0.00444	CcSEcCtD
Toremifene—Leukopenia—Simvastatin—atherosclerosis	0.00055	0.00443	CcSEcCtD
Toremifene—Chest pain—Ezetimibe—atherosclerosis	0.000548	0.00442	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000545	0.00439	CcSEcCtD
Toremifene—Pain—Rosuvastatin—atherosclerosis	0.000541	0.00435	CcSEcCtD
Toremifene—Constipation—Rosuvastatin—atherosclerosis	0.000541	0.00435	CcSEcCtD
Toremifene—Vision blurred—Niacin—atherosclerosis	0.000532	0.00428	CcSEcCtD
Toremifene—Thrombocytopenia—Lovastatin—atherosclerosis	0.000525	0.00423	CcSEcCtD
Toremifene—Vision blurred—Pravastatin—atherosclerosis	0.000523	0.00421	CcSEcCtD
Toremifene—Chest pain—Simvastatin—atherosclerosis	0.000523	0.00421	CcSEcCtD
Toremifene—Tremor—Pravastatin—atherosclerosis	0.00052	0.00419	CcSEcCtD
Toremifene—Nervous system disorder—Ezetimibe—atherosclerosis	0.000516	0.00415	CcSEcCtD
Toremifene—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000515	0.00414	CcSEcCtD
Toremifene—Anorexia—Lovastatin—atherosclerosis	0.000511	0.00411	CcSEcCtD
Toremifene—Skin disorder—Ezetimibe—atherosclerosis	0.000511	0.00411	CcSEcCtD
Toremifene—Vertigo—Niacin—atherosclerosis	0.000507	0.00408	CcSEcCtD
Toremifene—Leukopenia—Niacin—atherosclerosis	0.000505	0.00407	CcSEcCtD
Toremifene—Oedema—Simvastatin—atherosclerosis	0.000501	0.00404	CcSEcCtD
Toremifene—Vertigo—Pravastatin—atherosclerosis	0.000499	0.00402	CcSEcCtD
Toremifene—Leukopenia—Pravastatin—atherosclerosis	0.000497	0.004	CcSEcCtD
Toremifene—Thrombocytopenia—Simvastatin—atherosclerosis	0.000491	0.00395	CcSEcCtD
Toremifene—Insomnia—Lovastatin—atherosclerosis	0.000485	0.0039	CcSEcCtD
Toremifene—Anorexia—Simvastatin—atherosclerosis	0.000478	0.00385	CcSEcCtD
Toremifene—Dyspnoea—Lovastatin—atherosclerosis	0.000478	0.00385	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000477	0.00384	CcSEcCtD
Toremifene—Insomnia—Ezetimibe—atherosclerosis	0.000475	0.00383	CcSEcCtD
Toremifene—Chest pain—Pravastatin—atherosclerosis	0.000473	0.00381	CcSEcCtD
Toremifene—Dyspnoea—Ezetimibe—atherosclerosis	0.000469	0.00377	CcSEcCtD
Toremifene—Decreased appetite—Lovastatin—atherosclerosis	0.000466	0.00375	CcSEcCtD
Toremifene—Fatigue—Lovastatin—atherosclerosis	0.000462	0.00372	CcSEcCtD
Toremifene—Oedema—Niacin—atherosclerosis	0.00046	0.00371	CcSEcCtD
Toremifene—Constipation—Lovastatin—atherosclerosis	0.000458	0.00369	CcSEcCtD
Toremifene—Pain—Lovastatin—atherosclerosis	0.000458	0.00369	CcSEcCtD
Toremifene—Decreased appetite—Ezetimibe—atherosclerosis	0.000457	0.00368	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000454	0.00365	CcSEcCtD
Toremifene—Asthenia—Rosuvastatin—atherosclerosis	0.000454	0.00365	CcSEcCtD
Toremifene—Insomnia—Simvastatin—atherosclerosis	0.000453	0.00365	CcSEcCtD
Toremifene—Oedema—Pravastatin—atherosclerosis	0.000453	0.00365	CcSEcCtD
Toremifene—Fatigue—Ezetimibe—atherosclerosis	0.000453	0.00365	CcSEcCtD
Toremifene—Constipation—Ezetimibe—atherosclerosis	0.00045	0.00362	CcSEcCtD
Toremifene—Pain—Ezetimibe—atherosclerosis	0.00045	0.00362	CcSEcCtD
Toremifene—Pruritus—Rosuvastatin—atherosclerosis	0.000447	0.0036	CcSEcCtD
Toremifene—Skin disorder—Niacin—atherosclerosis	0.000447	0.0036	CcSEcCtD
Toremifene—Dyspnoea—Simvastatin—atherosclerosis	0.000447	0.0036	CcSEcCtD
Toremifene—Hyperhidrosis—Niacin—atherosclerosis	0.000445	0.00358	CcSEcCtD
Toremifene—Thrombocytopenia—Pravastatin—atherosclerosis	0.000444	0.00357	CcSEcCtD
Toremifene—Anorexia—Niacin—atherosclerosis	0.000439	0.00353	CcSEcCtD
Toremifene—Hyperhidrosis—Pravastatin—atherosclerosis	0.000438	0.00353	CcSEcCtD
Toremifene—Decreased appetite—Simvastatin—atherosclerosis	0.000436	0.00351	CcSEcCtD
Toremifene—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000433	0.00349	CcSEcCtD
Toremifene—Fatigue—Simvastatin—atherosclerosis	0.000432	0.00348	CcSEcCtD
Toremifene—Anorexia—Pravastatin—atherosclerosis	0.000432	0.00348	CcSEcCtD
Toremifene—Pain—Simvastatin—atherosclerosis	0.000429	0.00345	CcSEcCtD
Toremifene—Constipation—Simvastatin—atherosclerosis	0.000429	0.00345	CcSEcCtD
Toremifene—Dizziness—Rosuvastatin—atherosclerosis	0.000418	0.00337	CcSEcCtD
Toremifene—Insomnia—Niacin—atherosclerosis	0.000416	0.00335	CcSEcCtD
Toremifene—Dyspnoea—Niacin—atherosclerosis	0.00041	0.0033	CcSEcCtD
Toremifene—Insomnia—Pravastatin—atherosclerosis	0.00041	0.0033	CcSEcCtD
Toremifene—Dyspnoea—Pravastatin—atherosclerosis	0.000404	0.00325	CcSEcCtD
Toremifene—Decreased appetite—Niacin—atherosclerosis	0.0004	0.00322	CcSEcCtD
Toremifene—Rash—Rosuvastatin—atherosclerosis	0.000399	0.00321	CcSEcCtD
Toremifene—Dermatitis—Rosuvastatin—atherosclerosis	0.000398	0.00321	CcSEcCtD
Toremifene—Gastrointestinal disorder—Niacin—atherosclerosis	0.000397	0.0032	CcSEcCtD
Toremifene—Headache—Rosuvastatin—atherosclerosis	0.000396	0.00319	CcSEcCtD
Toremifene—Decreased appetite—Pravastatin—atherosclerosis	0.000394	0.00317	CcSEcCtD
Toremifene—Pain—Niacin—atherosclerosis	0.000394	0.00317	CcSEcCtD
Toremifene—Fatigue—Pravastatin—atherosclerosis	0.000391	0.00315	CcSEcCtD
Toremifene—Clomifene—ESR1—atherosclerosis	0.000389	0.0805	CrCbGaD
Toremifene—Constipation—Pravastatin—atherosclerosis	0.000388	0.00312	CcSEcCtD
Toremifene—Pain—Pravastatin—atherosclerosis	0.000388	0.00312	CcSEcCtD
Toremifene—Asthenia—Lovastatin—atherosclerosis	0.000385	0.0031	CcSEcCtD
Toremifene—Pruritus—Lovastatin—atherosclerosis	0.000379	0.00305	CcSEcCtD
Toremifene—Asthenia—Ezetimibe—atherosclerosis	0.000377	0.00304	CcSEcCtD
Toremifene—Nausea—Rosuvastatin—atherosclerosis	0.000376	0.00302	CcSEcCtD
Toremifene—Pruritus—Ezetimibe—atherosclerosis	0.000372	0.00299	CcSEcCtD
Toremifene—Asthenia—Simvastatin—atherosclerosis	0.00036	0.0029	CcSEcCtD
Toremifene—Diphenhydramine—HRH1—atherosclerosis	0.000356	0.0736	CrCbGaD
Toremifene—Pruritus—Simvastatin—atherosclerosis	0.000355	0.00286	CcSEcCtD
Toremifene—Dizziness—Lovastatin—atherosclerosis	0.000354	0.00285	CcSEcCtD
Toremifene—Dizziness—Ezetimibe—atherosclerosis	0.000348	0.0028	CcSEcCtD
Toremifene—Vomiting—Lovastatin—atherosclerosis	0.000341	0.00274	CcSEcCtD
Toremifene—Rash—Lovastatin—atherosclerosis	0.000338	0.00272	CcSEcCtD
Toremifene—Dermatitis—Lovastatin—atherosclerosis	0.000338	0.00272	CcSEcCtD
Toremifene—Orphenadrine—HRH1—atherosclerosis	0.000337	0.0697	CrCbGaD
Toremifene—Headache—Lovastatin—atherosclerosis	0.000336	0.0027	CcSEcCtD
Toremifene—Vomiting—Ezetimibe—atherosclerosis	0.000334	0.00269	CcSEcCtD
Toremifene—Dizziness—Simvastatin—atherosclerosis	0.000332	0.00267	CcSEcCtD
Toremifene—Rash—Ezetimibe—atherosclerosis	0.000331	0.00267	CcSEcCtD
Toremifene—Dermatitis—Ezetimibe—atherosclerosis	0.000331	0.00267	CcSEcCtD
Toremifene—Asthenia—Niacin—atherosclerosis	0.00033	0.00266	CcSEcCtD
Toremifene—Headache—Ezetimibe—atherosclerosis	0.000329	0.00265	CcSEcCtD
Toremifene—Pruritus—Niacin—atherosclerosis	0.000326	0.00262	CcSEcCtD
Toremifene—Asthenia—Pravastatin—atherosclerosis	0.000325	0.00262	CcSEcCtD
Toremifene—Pruritus—Pravastatin—atherosclerosis	0.000321	0.00258	CcSEcCtD
Toremifene—Vomiting—Simvastatin—atherosclerosis	0.000319	0.00257	CcSEcCtD
Toremifene—Nausea—Lovastatin—atherosclerosis	0.000318	0.00256	CcSEcCtD
Toremifene—Rash—Simvastatin—atherosclerosis	0.000316	0.00255	CcSEcCtD
Toremifene—Dermatitis—Simvastatin—atherosclerosis	0.000316	0.00254	CcSEcCtD
Toremifene—Headache—Simvastatin—atherosclerosis	0.000314	0.00253	CcSEcCtD
Toremifene—Nausea—Ezetimibe—atherosclerosis	0.000312	0.00251	CcSEcCtD
Toremifene—Dizziness—Niacin—atherosclerosis	0.000304	0.00245	CcSEcCtD
Toremifene—Dizziness—Pravastatin—atherosclerosis	0.0003	0.00241	CcSEcCtD
Toremifene—Nausea—Simvastatin—atherosclerosis	0.000298	0.0024	CcSEcCtD
Toremifene—Vomiting—Niacin—atherosclerosis	0.000293	0.00236	CcSEcCtD
Toremifene—Tamoxifen—ESR2—atherosclerosis	0.000292	0.0604	CrCbGaD
Toremifene—Rash—Niacin—atherosclerosis	0.00029	0.00234	CcSEcCtD
Toremifene—Dermatitis—Niacin—atherosclerosis	0.00029	0.00233	CcSEcCtD
Toremifene—Headache—Niacin—atherosclerosis	0.000288	0.00232	CcSEcCtD
Toremifene—Vomiting—Pravastatin—atherosclerosis	0.000288	0.00232	CcSEcCtD
Toremifene—Rash—Pravastatin—atherosclerosis	0.000286	0.0023	CcSEcCtD
Toremifene—Dermatitis—Pravastatin—atherosclerosis	0.000286	0.0023	CcSEcCtD
Toremifene—Headache—Pravastatin—atherosclerosis	0.000284	0.00229	CcSEcCtD
Toremifene—Nausea—Niacin—atherosclerosis	0.000273	0.0022	CcSEcCtD
Toremifene—Nausea—Pravastatin—atherosclerosis	0.000269	0.00217	CcSEcCtD
Toremifene—Tamoxifen—ESR1—atherosclerosis	0.00018	0.0372	CrCbGaD
Toremifene—ESR1—Signaling Pathways—VWF—atherosclerosis	2.27e-05	0.000353	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SIRT1—atherosclerosis	2.27e-05	0.000352	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPA—atherosclerosis	2.27e-05	0.000352	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOC3—atherosclerosis	2.26e-05	0.000351	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.25e-05	0.000349	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FABP4—atherosclerosis	2.25e-05	0.000349	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LCAT—atherosclerosis	2.25e-05	0.000349	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LDLR—atherosclerosis	2.25e-05	0.000349	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.22e-05	0.000345	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA4—atherosclerosis	2.21e-05	0.000342	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BGN—atherosclerosis	2.2e-05	0.000341	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL3—atherosclerosis	2.19e-05	0.000341	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.18e-05	0.000339	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA5—atherosclerosis	2.17e-05	0.000338	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.17e-05	0.000336	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLTP—atherosclerosis	2.15e-05	0.000334	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.14e-05	0.000332	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.11e-05	0.000328	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCF1—atherosclerosis	2.1e-05	0.000326	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	2.09e-05	0.000325	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.07e-05	0.000321	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.05e-05	0.000318	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.05e-05	0.000318	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.05e-05	0.000318	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALOX5—atherosclerosis	2.02e-05	0.000314	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.02e-05	0.000314	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.01e-05	0.000311	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP27A1—atherosclerosis	2e-05	0.000311	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDNRA—atherosclerosis	1.98e-05	0.000308	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR2—atherosclerosis	1.98e-05	0.000308	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CYBA—atherosclerosis	1.98e-05	0.000307	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.96e-05	0.000305	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.96e-05	0.000304	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PLAT—atherosclerosis	1.93e-05	0.0003	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PARP1—atherosclerosis	1.93e-05	0.0003	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GHRL—atherosclerosis	1.93e-05	0.0003	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.91e-05	0.000296	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.9e-05	0.000295	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALOX15—atherosclerosis	1.9e-05	0.000295	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.9e-05	0.000295	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA2—atherosclerosis	1.9e-05	0.000295	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARA—atherosclerosis	1.89e-05	0.000293	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCG5—atherosclerosis	1.88e-05	0.000291	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.87e-05	0.00029	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.86e-05	0.000289	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.86e-05	0.000289	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.83e-05	0.000284	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NAMPT—atherosclerosis	1.81e-05	0.000281	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPA—atherosclerosis	1.81e-05	0.000281	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.8e-05	0.00028	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LIPC—atherosclerosis	1.8e-05	0.00028	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FABP4—atherosclerosis	1.79e-05	0.000279	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LCAT—atherosclerosis	1.79e-05	0.000279	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOC3—atherosclerosis	1.79e-05	0.000278	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LDLR—atherosclerosis	1.78e-05	0.000276	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA4—atherosclerosis	1.76e-05	0.000273	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BGN—atherosclerosis	1.75e-05	0.000272	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CETP—atherosclerosis	1.74e-05	0.00027	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA5—atherosclerosis	1.74e-05	0.00027	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.73e-05	0.000269	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KNG1—atherosclerosis	1.7e-05	0.000264	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGTR1—atherosclerosis	1.69e-05	0.000262	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.67e-05	0.00026	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SCARB1—atherosclerosis	1.66e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.66e-05	0.000257	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.65e-05	0.000256	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PLG—atherosclerosis	1.64e-05	0.000255	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.62e-05	0.000252	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALOX5—atherosclerosis	1.61e-05	0.000251	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.6e-05	0.000248	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.57e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.57e-05	0.000244	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—atherosclerosis	1.56e-05	0.000242	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.56e-05	0.000242	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.55e-05	0.000241	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.54e-05	0.000238	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA2—atherosclerosis	1.52e-05	0.000235	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.52e-05	0.000235	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.52e-05	0.000235	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.52e-05	0.000235	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.5e-05	0.000233	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.5e-05	0.000232	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.5e-05	0.000232	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.5e-05	0.000232	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.47e-05	0.000229	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOB—atherosclerosis	1.45e-05	0.000226	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAMPT—atherosclerosis	1.45e-05	0.000225	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPA—atherosclerosis	1.45e-05	0.000225	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LIPC—atherosclerosis	1.44e-05	0.000223	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—atherosclerosis	1.43e-05	0.000222	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOC3—atherosclerosis	1.43e-05	0.000222	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LDLR—atherosclerosis	1.42e-05	0.000221	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL5—atherosclerosis	1.42e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.42e-05	0.00022	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—atherosclerosis	1.4e-05	0.000218	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.4e-05	0.000218	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BGN—atherosclerosis	1.4e-05	0.000217	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.39e-05	0.000216	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CETP—atherosclerosis	1.39e-05	0.000216	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LPL—atherosclerosis	1.39e-05	0.000215	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA5—atherosclerosis	1.39e-05	0.000215	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FABP4—atherosclerosis	1.38e-05	0.000215	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LCAT—atherosclerosis	1.38e-05	0.000215	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.36e-05	0.000212	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA4—atherosclerosis	1.36e-05	0.000211	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCG—atherosclerosis	1.35e-05	0.00021	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.35e-05	0.000209	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.34e-05	0.000207	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.33e-05	0.000207	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SCARB1—atherosclerosis	1.33e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.32e-05	0.000205	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—atherosclerosis	1.31e-05	0.000204	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.31e-05	0.000203	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.3e-05	0.000203	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.29e-05	0.0002	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMGCR—atherosclerosis	1.26e-05	0.000195	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.23e-05	0.000192	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.23e-05	0.000191	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.22e-05	0.000189	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.2e-05	0.000187	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.19e-05	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGT—atherosclerosis	1.19e-05	0.000184	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.17e-05	0.000182	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.17e-05	0.000182	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.17e-05	0.000182	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA2—atherosclerosis	1.17e-05	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—atherosclerosis	1.16e-05	0.000181	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—atherosclerosis	1.16e-05	0.000181	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.16e-05	0.000179	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.16e-05	0.000179	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.15e-05	0.000179	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOB—atherosclerosis	1.15e-05	0.000179	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.15e-05	0.000179	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.15e-05	0.000178	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LIPC—atherosclerosis	1.15e-05	0.000178	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOC3—atherosclerosis	1.14e-05	0.000177	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LDLR—atherosclerosis	1.13e-05	0.000176	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.12e-05	0.000174	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCA1—atherosclerosis	1.12e-05	0.000174	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPA—atherosclerosis	1.12e-05	0.000173	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CETP—atherosclerosis	1.11e-05	0.000172	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPL—atherosclerosis	1.1e-05	0.000171	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—atherosclerosis	1.1e-05	0.00017	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BGN—atherosclerosis	1.08e-05	0.000168	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—atherosclerosis	1.07e-05	0.000167	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA5—atherosclerosis	1.07e-05	0.000166	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.06e-05	0.000165	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.05e-05	0.000163	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD36—atherosclerosis	1.04e-05	0.000162	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.03e-05	0.00016	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.03e-05	0.00016	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMGCR—atherosclerosis	1e-05	0.000156	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.95e-06	0.000154	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—atherosclerosis	9.94e-06	0.000154	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—atherosclerosis	9.9e-06	0.000154	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—atherosclerosis	9.78e-06	0.000152	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARA—atherosclerosis	9.71e-06	0.000151	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—atherosclerosis	9.61e-06	0.000149	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—atherosclerosis	9.6e-06	0.000149	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AGT—atherosclerosis	9.41e-06	0.000146	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—atherosclerosis	9.22e-06	0.000143	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOB—atherosclerosis	9.2e-06	0.000143	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—atherosclerosis	9.14e-06	0.000142	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—atherosclerosis	9.13e-06	0.000142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	9.13e-06	0.000142	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA1—atherosclerosis	9.11e-06	0.000141	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.04e-06	0.00014	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—atherosclerosis	8.95e-06	0.000139	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.93e-06	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.92e-06	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LIPC—atherosclerosis	8.87e-06	0.000138	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOC3—atherosclerosis	8.81e-06	0.000137	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPL—atherosclerosis	8.78e-06	0.000136	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LDLR—atherosclerosis	8.76e-06	0.000136	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—atherosclerosis	8.72e-06	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—atherosclerosis	8.57e-06	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CETP—atherosclerosis	8.55e-06	0.000133	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD36—atherosclerosis	8.34e-06	0.00013	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—atherosclerosis	8.32e-06	0.000129	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.19e-06	0.000127	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—atherosclerosis	8.03e-06	0.000125	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—atherosclerosis	7.91e-06	0.000123	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—atherosclerosis	7.87e-06	0.000122	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARA—atherosclerosis	7.76e-06	0.00012	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.74e-06	0.00012	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—atherosclerosis	7.73e-06	0.00012	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.66e-06	0.000119	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AGT—atherosclerosis	7.51e-06	0.000117	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—atherosclerosis	7.36e-06	0.000114	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOB—atherosclerosis	7.34e-06	0.000114	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—atherosclerosis	7.29e-06	0.000113	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA1—atherosclerosis	7.28e-06	0.000113	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—atherosclerosis	7.22e-06	0.000112	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.14e-06	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPL—atherosclerosis	7.01e-06	0.000109	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—atherosclerosis	6.99e-06	0.000109	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKB1—atherosclerosis	6.92e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—atherosclerosis	6.9e-06	0.000107	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.89e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—atherosclerosis	6.84e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—atherosclerosis	6.8e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD36—atherosclerosis	6.66e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.64e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—atherosclerosis	6.41e-06	9.95e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—atherosclerosis	6.31e-06	9.8e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.31e-06	9.8e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—atherosclerosis	6.29e-06	9.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—atherosclerosis	6.28e-06	9.75e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—atherosclerosis	6.22e-06	9.65e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARA—atherosclerosis	6.19e-06	9.61e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—atherosclerosis	6.16e-06	9.57e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AGT—atherosclerosis	6e-06	9.31e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—atherosclerosis	5.94e-06	9.22e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.92e-06	9.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—atherosclerosis	5.88e-06	9.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—atherosclerosis	5.82e-06	9.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA1—atherosclerosis	5.81e-06	9.02e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—atherosclerosis	5.76e-06	8.95e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—atherosclerosis	5.76e-06	8.95e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOB—atherosclerosis	5.67e-06	8.8e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—atherosclerosis	5.51e-06	8.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.51e-06	8.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPL—atherosclerosis	5.41e-06	8.4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.3e-06	8.23e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—atherosclerosis	5.28e-06	8.2e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD36—atherosclerosis	5.14e-06	7.98e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—atherosclerosis	5.12e-06	7.95e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—atherosclerosis	5.04e-06	7.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—atherosclerosis	5.02e-06	7.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.87e-06	7.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARA—atherosclerosis	4.78e-06	7.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AGT—atherosclerosis	4.63e-06	7.19e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—atherosclerosis	4.6e-06	7.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—atherosclerosis	4.53e-06	7.04e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—atherosclerosis	4.49e-06	6.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA1—atherosclerosis	4.48e-06	6.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—atherosclerosis	4.4e-06	6.83e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—atherosclerosis	4.34e-06	6.74e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.09e-06	6.35e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.03e-06	6.25e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—atherosclerosis	4.01e-06	6.22e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—atherosclerosis	3.95e-06	6.13e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—atherosclerosis	3.87e-06	6.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—atherosclerosis	3.55e-06	5.51e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—atherosclerosis	3.4e-06	5.27e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—atherosclerosis	3.17e-06	4.93e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.11e-06	4.82e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—atherosclerosis	2.53e-06	3.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—atherosclerosis	2.02e-06	3.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—atherosclerosis	1.56e-06	2.42e-05	CbGpPWpGaD
